Sign In
Buy RXST
$5.06
+0.110 (+2.22%)
At Close: Jul 13, 2026
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook
10:02pm, Friday, 10'th Jul 2026
RxSight NASDAQ: RXST reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with m
RxSight: After Dropping To The Bottom, It's Time To Pick It Up
02:20pm, Friday, 10'th Jul 2026
RxSight, Inc. exhibits quantitative similarities to other small caps that I have rated here on Seeking Alpha that strongly outperformed the market. RXST is an 'NCAV' opportunity, a company that sells
Glancy Prongay Wolke & Rotter LLP Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
02:00pm, Friday, 10'th Jul 2026
[url="]Glancy Prongay Wolke and Rotter LLP[/url], a leading national shareholder rights law firm, today announced that it is investigating potential claims agains
Glancy Prongay Wolke & Rotter LLP Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
01:55pm, Friday, 10'th Jul 2026
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it is investigating potential claims against the board of director
Law Offices of Howard G. Smith Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
12:00pm, Wednesday, 08'th Jul 2026
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces it is investigating potential claims against the board of directors of RxSight, Inc. (“RxSight” or the “Company”) (NASD
The Law Offices of Frank R. Cruz Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
03:05pm, Tuesday, 07'th Jul 2026
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) con
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
10:32am, Tuesday, 07'th Jul 2026
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone pr
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
04:15pm, Monday, 06'th Jul 2026
ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ: RXST), an ophthalmic
Did RxSight, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
03:02pm, Thursday, 02'nd Jul 2026
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
04:10pm, Tuesday, 19'th May 2026
ALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is schedule
RxSight, Inc. (RXST) Presents at Bank of America Global Healthcare Conference 2026 Transcript
07:20pm, Wednesday, 13'th May 2026
RxSight, Inc. (RXST) Presents at Bank of America Global Healthcare Conference 2026 Transcript
RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript
04:31pm, Saturday, 09'th May 2026
RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates
07:31pm, Wednesday, 06'th May 2026
RxSight, Inc. (RXST) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.03 per share a year ago.
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
04:05pm, Wednesday, 06'th May 2026
ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026.
